Cargando…

Pathogenic mycobacteria achieve cellular persistence by inhibiting the Niemann-Pick Type C disease cellular pathway

Background. Tuberculosis remains a major global health concern. The ability to prevent phagosome-lysosome fusion is a key mechanism by which intracellular mycobacteria, including Mycobacterium tuberculosis, achieve long-term persistence within host cells. The mechanisms underpinning this key intrace...

Descripción completa

Detalles Bibliográficos
Autores principales: Fineran, Paul, Lloyd-Evans, Emyr, Lack, Nathan A., Platt, Nick, Davis, Lianne C., Morgan, Anthony J., Höglinger, Doris, Tatituri, Raju Venkata V., Clark, Simon, Williams, Ian M., Tynan, Patricia, Al Eisa, Nada, Nazarova, Evgeniya, Williams, Ann, Galione, Antony, Ory, Daniel S., Besra, Gurdyal S., Russell, David G., Brenner, Michael B., Sim, Edith, Platt, Frances M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: F1000Research 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5172425/
https://www.ncbi.nlm.nih.gov/pubmed/28008422
http://dx.doi.org/10.12688/wellcomeopenres.10036.2
_version_ 1782484126755979264
author Fineran, Paul
Lloyd-Evans, Emyr
Lack, Nathan A.
Platt, Nick
Davis, Lianne C.
Morgan, Anthony J.
Höglinger, Doris
Tatituri, Raju Venkata V.
Clark, Simon
Williams, Ian M.
Tynan, Patricia
Al Eisa, Nada
Nazarova, Evgeniya
Williams, Ann
Galione, Antony
Ory, Daniel S.
Besra, Gurdyal S.
Russell, David G.
Brenner, Michael B.
Sim, Edith
Platt, Frances M.
author_facet Fineran, Paul
Lloyd-Evans, Emyr
Lack, Nathan A.
Platt, Nick
Davis, Lianne C.
Morgan, Anthony J.
Höglinger, Doris
Tatituri, Raju Venkata V.
Clark, Simon
Williams, Ian M.
Tynan, Patricia
Al Eisa, Nada
Nazarova, Evgeniya
Williams, Ann
Galione, Antony
Ory, Daniel S.
Besra, Gurdyal S.
Russell, David G.
Brenner, Michael B.
Sim, Edith
Platt, Frances M.
author_sort Fineran, Paul
collection PubMed
description Background. Tuberculosis remains a major global health concern. The ability to prevent phagosome-lysosome fusion is a key mechanism by which intracellular mycobacteria, including Mycobacterium tuberculosis, achieve long-term persistence within host cells. The mechanisms underpinning this key intracellular pro-survival strategy remain incompletely understood. Host macrophages infected with intracellular mycobacteria share phenotypic similarities with cells taken from patients suffering from Niemann-Pick Disease Type C (NPC), a rare lysosomal storage disease in which endocytic trafficking defects and lipid accumulation within the lysosome lead to cell dysfunction and cell death. We investigated whether these shared phenotypes reflected an underlying mechanistic connection between mycobacterial intracellular persistence and the host cell pathway dysfunctional in NPC.  Methods. The induction of NPC phenotypes in macrophages from wild-type mice or obtained from healthy human donors was assessed via infection with mycobacteria and subsequent measurement of lipid levels and intracellular calcium homeostasis. The effect of NPC therapeutics on intracellular mycobacterial load was also assessed.  Results. Macrophages infected with intracellular mycobacteria phenocopied NPC cells, exhibiting accumulation of multiple lipid types, reduced lysosomal Ca (2+ )levels, and defects in intracellular trafficking. These NPC phenotypes could also be induced using only lipids/glycomycolates from the mycobacterial cell wall. These data suggest that intracellular mycobacteria inhibit the NPC pathway, likely via inhibition of the NPC1 protein, and subsequently induce altered acidic store Ca (2+) homeostasis. Reduced lysosomal calcium levels may provide a mechanistic explanation for the reduced levels of phagosome-lysosome fusion in mycobacterial infection. Treatments capable of correcting defects in NPC mutant cells via modulation of host cell calcium were of benefit in promoting clearance of mycobacteria from infected host cells.  Conclusion. These findings provide a novel mechanistic explanation for mycobacterial intracellular persistence, and suggest that targeting interactions between the mycobacteria and host cell pathways may provide a novel avenue for development of anti-TB therapies.
format Online
Article
Text
id pubmed-5172425
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher F1000Research
record_format MEDLINE/PubMed
spelling pubmed-51724252016-12-20 Pathogenic mycobacteria achieve cellular persistence by inhibiting the Niemann-Pick Type C disease cellular pathway Fineran, Paul Lloyd-Evans, Emyr Lack, Nathan A. Platt, Nick Davis, Lianne C. Morgan, Anthony J. Höglinger, Doris Tatituri, Raju Venkata V. Clark, Simon Williams, Ian M. Tynan, Patricia Al Eisa, Nada Nazarova, Evgeniya Williams, Ann Galione, Antony Ory, Daniel S. Besra, Gurdyal S. Russell, David G. Brenner, Michael B. Sim, Edith Platt, Frances M. Wellcome Open Res Research Article Background. Tuberculosis remains a major global health concern. The ability to prevent phagosome-lysosome fusion is a key mechanism by which intracellular mycobacteria, including Mycobacterium tuberculosis, achieve long-term persistence within host cells. The mechanisms underpinning this key intracellular pro-survival strategy remain incompletely understood. Host macrophages infected with intracellular mycobacteria share phenotypic similarities with cells taken from patients suffering from Niemann-Pick Disease Type C (NPC), a rare lysosomal storage disease in which endocytic trafficking defects and lipid accumulation within the lysosome lead to cell dysfunction and cell death. We investigated whether these shared phenotypes reflected an underlying mechanistic connection between mycobacterial intracellular persistence and the host cell pathway dysfunctional in NPC.  Methods. The induction of NPC phenotypes in macrophages from wild-type mice or obtained from healthy human donors was assessed via infection with mycobacteria and subsequent measurement of lipid levels and intracellular calcium homeostasis. The effect of NPC therapeutics on intracellular mycobacterial load was also assessed.  Results. Macrophages infected with intracellular mycobacteria phenocopied NPC cells, exhibiting accumulation of multiple lipid types, reduced lysosomal Ca (2+ )levels, and defects in intracellular trafficking. These NPC phenotypes could also be induced using only lipids/glycomycolates from the mycobacterial cell wall. These data suggest that intracellular mycobacteria inhibit the NPC pathway, likely via inhibition of the NPC1 protein, and subsequently induce altered acidic store Ca (2+) homeostasis. Reduced lysosomal calcium levels may provide a mechanistic explanation for the reduced levels of phagosome-lysosome fusion in mycobacterial infection. Treatments capable of correcting defects in NPC mutant cells via modulation of host cell calcium were of benefit in promoting clearance of mycobacteria from infected host cells.  Conclusion. These findings provide a novel mechanistic explanation for mycobacterial intracellular persistence, and suggest that targeting interactions between the mycobacteria and host cell pathways may provide a novel avenue for development of anti-TB therapies. F1000Research 2017-06-21 /pmc/articles/PMC5172425/ /pubmed/28008422 http://dx.doi.org/10.12688/wellcomeopenres.10036.2 Text en Copyright: © 2017 Fineran P et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Fineran, Paul
Lloyd-Evans, Emyr
Lack, Nathan A.
Platt, Nick
Davis, Lianne C.
Morgan, Anthony J.
Höglinger, Doris
Tatituri, Raju Venkata V.
Clark, Simon
Williams, Ian M.
Tynan, Patricia
Al Eisa, Nada
Nazarova, Evgeniya
Williams, Ann
Galione, Antony
Ory, Daniel S.
Besra, Gurdyal S.
Russell, David G.
Brenner, Michael B.
Sim, Edith
Platt, Frances M.
Pathogenic mycobacteria achieve cellular persistence by inhibiting the Niemann-Pick Type C disease cellular pathway
title Pathogenic mycobacteria achieve cellular persistence by inhibiting the Niemann-Pick Type C disease cellular pathway
title_full Pathogenic mycobacteria achieve cellular persistence by inhibiting the Niemann-Pick Type C disease cellular pathway
title_fullStr Pathogenic mycobacteria achieve cellular persistence by inhibiting the Niemann-Pick Type C disease cellular pathway
title_full_unstemmed Pathogenic mycobacteria achieve cellular persistence by inhibiting the Niemann-Pick Type C disease cellular pathway
title_short Pathogenic mycobacteria achieve cellular persistence by inhibiting the Niemann-Pick Type C disease cellular pathway
title_sort pathogenic mycobacteria achieve cellular persistence by inhibiting the niemann-pick type c disease cellular pathway
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5172425/
https://www.ncbi.nlm.nih.gov/pubmed/28008422
http://dx.doi.org/10.12688/wellcomeopenres.10036.2
work_keys_str_mv AT fineranpaul pathogenicmycobacteriaachievecellularpersistencebyinhibitingtheniemannpicktypecdiseasecellularpathway
AT lloydevansemyr pathogenicmycobacteriaachievecellularpersistencebyinhibitingtheniemannpicktypecdiseasecellularpathway
AT lacknathana pathogenicmycobacteriaachievecellularpersistencebyinhibitingtheniemannpicktypecdiseasecellularpathway
AT plattnick pathogenicmycobacteriaachievecellularpersistencebyinhibitingtheniemannpicktypecdiseasecellularpathway
AT davisliannec pathogenicmycobacteriaachievecellularpersistencebyinhibitingtheniemannpicktypecdiseasecellularpathway
AT morgananthonyj pathogenicmycobacteriaachievecellularpersistencebyinhibitingtheniemannpicktypecdiseasecellularpathway
AT hoglingerdoris pathogenicmycobacteriaachievecellularpersistencebyinhibitingtheniemannpicktypecdiseasecellularpathway
AT tatiturirajuvenkatav pathogenicmycobacteriaachievecellularpersistencebyinhibitingtheniemannpicktypecdiseasecellularpathway
AT clarksimon pathogenicmycobacteriaachievecellularpersistencebyinhibitingtheniemannpicktypecdiseasecellularpathway
AT williamsianm pathogenicmycobacteriaachievecellularpersistencebyinhibitingtheniemannpicktypecdiseasecellularpathway
AT tynanpatricia pathogenicmycobacteriaachievecellularpersistencebyinhibitingtheniemannpicktypecdiseasecellularpathway
AT aleisanada pathogenicmycobacteriaachievecellularpersistencebyinhibitingtheniemannpicktypecdiseasecellularpathway
AT nazarovaevgeniya pathogenicmycobacteriaachievecellularpersistencebyinhibitingtheniemannpicktypecdiseasecellularpathway
AT williamsann pathogenicmycobacteriaachievecellularpersistencebyinhibitingtheniemannpicktypecdiseasecellularpathway
AT galioneantony pathogenicmycobacteriaachievecellularpersistencebyinhibitingtheniemannpicktypecdiseasecellularpathway
AT orydaniels pathogenicmycobacteriaachievecellularpersistencebyinhibitingtheniemannpicktypecdiseasecellularpathway
AT besragurdyals pathogenicmycobacteriaachievecellularpersistencebyinhibitingtheniemannpicktypecdiseasecellularpathway
AT russelldavidg pathogenicmycobacteriaachievecellularpersistencebyinhibitingtheniemannpicktypecdiseasecellularpathway
AT brennermichaelb pathogenicmycobacteriaachievecellularpersistencebyinhibitingtheniemannpicktypecdiseasecellularpathway
AT simedith pathogenicmycobacteriaachievecellularpersistencebyinhibitingtheniemannpicktypecdiseasecellularpathway
AT plattfrancesm pathogenicmycobacteriaachievecellularpersistencebyinhibitingtheniemannpicktypecdiseasecellularpathway